zodasiran Injection

Drug identity checked against registry records

Also recorded as ARO-ANG3

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)NCT07037771Arrowhead PharmaceuticalsPhase 3Active not recruiting2027-08-20Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.